Skin biopsies were obtained from family members and 87 individuals in whom there was no family history of cystic fibrosis. This control group comprised 55 normal healthy individuals, and 32 patients with a variety of other diseases. Two biopsies were taken on different occasions from two affected individuals. Split thickness biopsies were taken without anesthesia from the extensor surface of the upper arm. Each biopsy was cut into several small pieces and each piece scratched into the floor of a Petri dish and grown in Eagle's minimum essential medium with 20% human AB serum and 5% beef embryonic extract ultrafiltrate (11) in an atmosphere of 5% CO2. On several occasions, biopsies were divided into two parts, one part for cell culture and the other for histological study. After the second trypsinization, 2-6 wk after the initial biopsy was taken, the cell lines were transferred to flasks for subsequent propagation as monolayer cultures on glass. The cultures were then grown in reinforced Eagie's medium (12) with 10% newborn calf or fetal calf serum. Bovine sera from several different commercial sources were used.
Cover slips were introduced into the Petri dish or flask culture at the time of subculturing for cytoplasmic studies. 1-7 days after subculturing, the cover slips were removed, washed in warm balanced salt solution, fixed in methanol, and stained with the metachromatic dye, tolnidine blue O, as previously described (13) .
Cytological evaluation of all preparations was based on the examination of 100 fields, each containing approximately 100 cells.
Tissue was obtained at autopsy from two patients (age 3 and 11) and one nonaffected individual (age 12). The first patient with the disease succumbed to an overwhelming gastro-intestinal infection with Shig~a sonnei; the second died of cardiac failure; and the nonaffected individual died following accidental trauma. Fibroblast cultures were established from the following tissues: adrenal, gall bladder, heart, kidney, liver, lung, pancreas, skin, spleen, testis, and thymus.
Ceil cultures derived from two patients with cystic fibrosis were analyzed quantitativdy for mucopolysaccharides (14) . Cell cultures from a patient of family 9, class IB, and from a patient of family 7, class II, were chosen in order to compare the two morphologically distinct groups with cultures derived from a normal, noncarrier individual and from a patient with the autosomal recessive type of Hurler's syndrome (13, 14) .
In order to obtain su~cient material for the chemical analyses, cells were grown in round bottles on a roller apparatus 1 in reinforced Eagle's medium (12) with 10% newborn calf serum at 2 rpm for approximately 4 wk. The medium was changed twice weekly and the pH maintained at approximately 7.4. After 1 month, the cells formed a dense, multilayered culture completely covering the glass surface. The cells were then harvested by decanting the medium, washing the culture twice with warm balanced salt solution, draining the culture bottle dry, and then freezing the cells adhering to the glass surface. After freezing, the culture was thawed and the cells scraped off the glass into distilled water. The aqueous cellular solution was then ~malyzed chemically (14) . The mucopolysaccharides were isolated by the method of Wessler, 2 the total polysaccharides estimated as uronic acid by the carbazole method (15) , and the hexose by the anthrone method (16) . Cell protein was determined by the method of Lowry et al (17) .
Biosynthesis of mucopolysaccharides was monitored using acetate-SI-I (320 #c/ml medium) to measure incorporation into the acetyl group of the hexosamine in the polysaccharide molecule, and sulfate-~S (30 #c/ml medium) to measure the addition of ester sulfate groups to the amino acid sugar residue of each repeating unit of the molecule as previously described (14) .
RESULTS

Li~ng C~tures.--
The establishment of cell lines from the original biopsy cultures took 2-6 wk, which was approximately the same length of time required to derive cell lines from normal, noncarriers of the same age. Under light microscopy, no difference in the rate of migration of cells from the biopsy or in mitotic activity was observed. Using phase-contrast microscopy, all the cells, irrespective of their source, contained cytoplasmic vacuoles and vesicles, and no difference in their shape, number, or phase density was detected.
Stained Cultures.--
Patients witk cystic fibrosis: Histological preparations of skin biopsies from affected individuals failed to reveal any intracellular metachromasia. In the skin fibroblast cultures derived from 19 individuals affected with cystic fibrosis, all showed cytoplasmic metachromasia. The morphological distribution of the metachromasia varied from discrete vesicles to metachromasia distributed diffusely throughout the cytoplasm in vesicles and granules (Figs. 2-4) . The cultures derived from each patient had such a consistent morphological ap-pearance under light microscopy that each could be assigned to one of two metachromafic categories, (I) vesicular and (II) generalized (vesicular-granular-cytoplasmic) ( Table II) . The class designated vesicular could be subdivided into those cultures showing few vesicles per cell (class IA) and those with many vesicles per cell (class IB). This division of class I into two subclasses was also evident if metachromasia was expressed in per cent of positive cells per culture. (Table III) . The second class, designated as generalized metachromasia, was characterized by fibroblasts with metachromasia distributed diffusely throughout the cytoplasm in vesicles and granules. This cytoplasmic metachromasia was similar to that previously seen in cultures derived from individuals with the genetic mucopolysaccharidoses (13) .
The constancy of the morphological appearance of the metachromasia of cultures derived from each patient was striking. Cell lines established from the same biopsy showed a remarkably similar degree of cellular metachromasia. Metachromasia of the cell cultures did not appear to be influenced by the sex, age of the donor, or time in culture beyond the fifth trypsinization (Table  IV) . In two families (Nos. 5 and 10), cultures were established from more than one affected sib. In family 5, all three boys were affected with both exocrine and pulmonary dysfunctions to a similar extent. Although the cultures derived from the affected boys could be classified as class II, the number of meta- chromatic cells per culture was markedly different (56, 90 and 11% respectively). I n family 10, the fibroblast cultures derived from the two affected boys were morphologically similar (class II). The elder, more mildly affected, had 45 % positive cells; whereas the younger, more severely affected, had 18% positive cells on repeated cultures. In neither family did the increase in metachromasia appear to be related to the severity of the disease or the age of the affected children. I t was particularly noteworthy that metachromasia was not observed in cultures in which the ceils were grown in medium containing adult human serum. Metachromasia became readily apparent, however, when the cells were grown in medium containing either newborn or fetal calf serum. The initial appearance of metachromasia varied from the first trypsinization of a monolayer culture grown in bovine serum to the fifth trypsinization. In families 3, 4, 8, and 16, the skin fibroblast cultures derived from the affected individuals showed essentially no metachromasia until after the third trypsinization. If a culture was subdivided at the first trypsinization, and one-half transferred to medium containing calf serum, the other half maintained ~n adult human serum, only the former developed metachromasia, irrespective of the length of time in culture. If a metachromatic culture was subcultured into medium containing serum of adult human rather than bovine origin, within a few days the culture became ametachromatic. The degree of cellular metachromasia increased during the first 2 months in culture and remained stable until the culture showed signs of senescence (approximately 30 subcultures).
Rele2ives of patients with cystic fibrosis: Of the 31 parents studied, all showed metachromasia (Tables III and IV) . Cultures derived from the parents, and those relatives with positive cultures, showed the same type of metachromasia as the affected individual (Table V) ; although cultures of the same age derived from a parent frequently showed more marked metachromasia than those from the affected offspring. Of the 20 grandparents from 10 families, 11 yielded positive cultures. In one family, No. 16, both maternal grandparents showed marked cellular metachromasia. Of the 15 sibs studied, 9 had cultures showing cellular metachromasia. In the 18 aunts and uncles studied, 15 had positive cultures (Tables IV and VI) . Variability in the initial appearance of cytoplasmic metachromasia was also seen in the cultures derived from the family members (Tables III and IV) . Once a culture became metachromatic, the per-cent of positive cells and the amount of metachromasia per cell remained remarkably constant.
Cellular metachromasia could not be used to distinguish the affected homozygous individual from the carrier by the type of metachromatic inclusions, the number of metachromatic cells per culture, or the amount of metachromatic material per cell. However, individual families could be allocated to classes IA, IB, or II by the morphological appearance of the metachromatic inclusions (Table V) . If the per cent of positive cells per culture was determined overlap between the two classes occurred (Table III) . Normal individuals: 86 of the 87 individuals in the control group examined showed no increase in cellular metachromasia, although approximately 1-3 % of the cells per culture showed some diffuse metachromasia.
In the cultures derived from the one "normal" individual, diffuse vesicular cytoplasmic metachromasia was seen similar to that observed for class II (Table IV) .
Autopsy tissue: Fibroblast cutures established from autopsy tissue from the normal, noncarrier child showed little intracellular metachromasia. Approximately 1-3 % of the cells in all cultures showed a diffuse metachromasia.
As with the tissue from the normal individual, the autopsy tissue of the two affected children grew very rapidly in culture; sublines being established in 2 wk. At the time of the first trypsinization, fibroblasts from all the tissues cultured showed cellular metachromasia of the vesicular type. Epithelial cells migrating from the original explants were not examined for metachromasia. The family of the first patient was not studied in cell culture The second patient was the affected individual in family 9 ( Table I ). The fibroblast cul-tures established from the parents showed the same vesicular inclusions and the family could be classified as class IB (Table II) .
Chemical Studies.-
In cell cultures derived from the affected individual in family 9 (Table VII) , the intraceUular uronic acid content (2.48 #g/mg cellular protein) was slightly less than seen in cultures derived from a normal, noncarrier individual (4.0 gg/mg cellular protein), whereas the hexose content of cells from both sources was similar (296 #g/mg cellular protein from the patient with cystic fibrosis, 289 #g/rag cellular protein for the normal individual). The intracellular uronic acid content of cultures derived from the affected individual in family 7 was markedly increased (10.4 vg/mg cellular protein), and was within the range found for fibrobJast cultures derived from a patient with Hurler's syndrome (11.0 ~g/mg cellular protein) grown in the laboratory at the same time under the same conditions. The hexose content of these cultures (310 jzg/mg cellular protein) as well as for those derived from the Hurler's syndrome (325 #g/rag cellular protein) were comparable to that determined for the cultures from the normal, noncarrier individual.
In the family 9 (class IB), the fibroblast cultures from both parents were markedly metachromatic although the amounts of intracellular uronic acid and hexose were comparable to those found in fibroblasts from a normal, noncarrier individual (Table vii) .
Estimation of mucopolysaccharide synthesis of these same cell cultures by the incorporation of acetate-3H and sulfate-85S into newly synthesized mucopolysaccharide agreed with the quantitative chemical analyses of intracellular uronic acid and hexose content (Table VII) . The incorporation of these two radioactive substances indicated that total polysaccharide synthesis and sulfation in the cultures derived from the affected patient and two heterozygotes of family 9 were comparable to that exhibited by cultures from a normal, noncarrier subject. Whereas, in skin fibroblast cultures derived from the affected individual of family 7 (class II), the incorporation of both radioactive markers was greater than for control cultures and similar to that determined for cultures derived from a patient with Hufler's syndrome (Table VII) .
DISCUSSION
It is ironic that, although cystic fibrosis is the commonest inherited disease in Caucasian populations, the genetically determined molecular defect is unknown. Most estimates of the prevalence of cystic fibrosis indicate that it occurs in about 1 in 1600 to 1 in 2000 births, with a calculated heterozygous carrier frequency of about 1 in 20 to 1 in 25 (1, 6) . The clinical features of cystic fibrosis suggest a genetic defect affecting exocrine glands; an increased sodium and chloride concentration of the sweat and an increased secretion of mucous throughout the body are almost constant findings. Although these abnormalities are restricted to the exocrine system, the possibility arose that a more generalized abnormality in cellular function might exist which could be detected in cultured fibroblasts derived from patients with the disease.
Recent studies on skin fibroblast cultures derived from patients with a wide spectrum of inherited metabolic disorders have shown that the skin fibroblast in culture can disclose the presence of an abnormal gene, even though in vivo the skin cells appear entirely normal. This increasing ability of the cultured human skin fibroblast to reveal its genetic constitution is proving to be extremely useful in investigating human inherited disease (8) .
Several investigators (1, 18) have reviewed the evidence that an abnormality of mucous secretion is the basic disorder in cystic fibrosis. However, the glycoprotein-rich secretions which are produced in excessive amount have not been found to differ qualitatively from those found in normal individuals (1) . The increase in mucous secretions in cystic fibrosis coupled with the studies on the genetic mucopolysaccharidoses in cell culture (13, 14, 19) suggested that skin fibroblasts derived from individuals with cystic fibrosis might show a demonstrable cytological abnormality.
Michaelis and Granick (20) introduced the concept that the polymerization of certain dyes by combination with substrates produces a change in their absorption causing metachromasia. Although it was thought (21) that all metachromatically-stained compounds were sulfuric acid esters, such as sul-fated carbohydrates, it is now recognized (22) that any macromolecule containing electronegative radicals and exhibiting a periodic negative surface charge may show metachromasia. Substances such as metaphosphates, nucleic acids, polypeptides, and tissue lipids have been found to give tissue metachromasia (23) . Cellular metachromasia has been observed in skin fibroblast cultures from the genetic mucopolysaccharidoses (13, 14, 19 ), Gaucher's disease (24) , lipomucopolysaccharidoses (25) (26) (27) , and familial amaurotic idiocy (28) . Thus, it has become apparent that a number of apparently diverse metabolic substances which accumulate intracellularly in skin fibroblast cultures derived from a number of genetic metabolic disorders will stain metachromatically with tolnidine blue O. The wide spectrum of these metabolic substances indicate the non-specificity of the metachromafic reaction. The metachromasia seen in skin fibroblast cultures derived from affected individuals and heterozygous carriers of cystic fibrosis is presumed to indicate only that the genetic defect, as yet unknown, is being expressed by skin fibroblasts in culture.
Cellular metachromasia was noted in cultures grown in newborn calf serum as early as 2-3 wk after establishment of the initial biopsy culture. As had been previously found in the mucopolysaccharidoses (14), cellular metachromasia appeared to be suppressed by the presence of adult human serum. Unlike the mucopolysaccharidoses, in which there appeared to be a latent culture period before metachromasia could be detected (14) , cellular metachromasia in cystic fibrosis was evident in 11 of the families as soon as cells migrated from the original explant, although the original biopsy tissue showed no such inclusions. However, the cultures derived from 11 members of 5 families showed some delay in developing metachromasia. The existence of a latent period in diseases, such as the mucopolysaccharidoses, which are associated with an intracellular accumulation of stainable material, is not unexpected.
The biopsies for this study were obtained at two clinics approximately 6 months apart. In both groups, irrespective of the length of growth time, the cultures segregated as families into two definite morphological classes of metachromasia (Tables II and V) . Class I showed only metachromatic vesicles and class II exhibited metachromasia diffusely throughout the cytoplasm in vesicles and granules. The metachromatic vesicles characteristic of class I were quite distinct from the cytoplasmic metachromasia seen in the generic mucopolysaccharidoses (13, 14), Gaucher's disease (24) , and familial amaurotic idiocy (28) . Although each fibroblast might be packed with vesicles (Figs. 2-4) , the material remained within the vesicles. The mucopolysaccharide content (measured as uronic acid and hexose content) and the amount of mucopolysaccharide synthesized (measured as incorporation of acetate-SH and sulfate-35S) of cultures derived from both an affected individual and two heterozygotes of the same family (No. 9) were comparable to that determined for cultures from homozygous normal individuals (Table VII) . Whether a distinct ametachromatic class will be identified will require additional studies.
In class II, the metachromasia was dispersed diffusely throughout the cyto-plasm, occurring in both vesicles and granules. Cultures derived from some fades in class II, including affected individuals and heterozygous carriers, could not be distinguished morphologically from cultures derived from families with the genetic mucopolysaccharidoses (Figs. 2-4) . However, these ceils did not assume the appearance of bloated gargoyle cells so frequently seen in the cultures from the X-linked Hunter's syndrome (13, 14) . Chemical studies from one affected individual of this class appeared to substantiate this cytological evaluation as the amount of intraceilular mucopolysaccharide was comparable to that seen in the genetic mucopolysaccharidoses (Table VII) (14) .
On the basis of the many comprehensive family studies, including segregation analysis (4--7), cystic fibrosis is clearly transmitted as an autosomal recessive trait. An increased prevalence of respiratory or gastrointestinal disease is not seen in the parents of patients with cystic fibrosis (29, 30) . Although the mean sweat sodium concentration (3, 31) and the sodium content of nails (32) are frequently increased in obligatory heterozygotes, the degree of overlap with normal subjects invalidates these tests for the detection of carriers. However, recent observations by Balfe et al. (33) suggest that a decrease in the active transport of sodium is demonstrable in erythrocytes from individuals heterozygous for cystic fibrosis. Recently, a bioassay for detecting carriers has been developed based on the observation that serum of carriers causes a dyskinesia of ciliary motility of rabbit tracheal cells (34) , or ciliary activity of certain mollusca 3 (35) .
In the 16 families studied in cell culture, the expression of the abnormal gene using cellular met&chromasia as the genetic marker could be traced through three generations of unaffected normal individuals (Fig. 1) . As all the parents of affected individuals yielded metachromatic fibroblast cultures, metachromasia appeared to be a reliable genetic marker for detecting heterozygotes under the conditions employed. Application of this cell culture method to other members of the families also revealed good agreement with the expected number of carriers and noncarriers except for the aunts and uncles where the number of carriers was in excess of the expected (Table VI) . The number of uncles and aunts examined is still small and it will be of interest to see whether this discrepancy is maintained when more relatives have been studied.
In family 16, both maternal grandparents had fibroblasts containing metachromasia and were thus presumed to be heterozygous carriers. The cytoplasmic metachromasia in this family was vesicular in type, class IA. The possibility, therefore, that one grandparent was a carrier of the cystic fibrosis gene and the other a carrier for a genetic mucopolysacharidosis could not be excluded on morphological grounds. Analysis of the intracellular mucopolysaccharide content of the cultured fibroblasts should allow resolution of this ambiguity. It should be emphasized that although the degree of metachromasia could not be used to distinguish affected individuals from heterozygous carriers, this distinction could be made clinically (Table III and IV) .
The distribution of affected and nonaffected offspring in families with cystic fibrosis according to mating types showed that there was good agreement between expected and observed in the positive X positive mafings (Table VIII) . In the positive X negative matings, the deviation from the expected may have been due to partial ascertainment of offspring from these mafings. If the obligatory carriers from positive X negative matings are excluded, the ratio of carriers to noncarriers would be expected to be 2:1; in the present study it was 3:1. Danks (6) , in a comprehensive study of 232 families with cystic fibrosis in Australia, estimated the heterozygote frequency to be 1 in 25.25 live births. The frequency of 1 carrier in 87 individuals in the "control" group is, there-fore, somewhat less than might have been expected. One of the two maternal grandparents (family 16), both of whom showed cytoplasmic metachromasia, could be considered to represent a randomly occurring "carrier." The high frequency of the recessive gene for cystic fibrosis in Caucasian populations is usually attributed to a small selective advantage of the heterozygous carrier necessary to maintain genetic equilibrium (36) . The unlikely possibility that the high frequency of cystic fibrosis in Caucasian populations has arisen as a result of drift cannot be rigorously excluded (37) . Both Danks (6) and Knudson et al. (36) observed that parents of children with cystic fibrosis came from larger sibships than did those from their control groups. * Since these mating types have been ascertained through parents of affected children, the 8 parents were excluded.
Danks (6) and Crow (7), the latter using family material reported by Steinberg (38) , concluded that the data were compatible with the existence of a single mutant gene. Childs (39) suggested that a system of alleles at one locus, or genes at different loci, might explain the variability of sweat electrolyte abnormalities in homozygous affected and heterozygous carriers in the same family. The finding of morphological heterogeneity in the present study (Figs.  2-4, Tables II, III , and V) is directly relevant to the problem of genetic heterogeneity. Indeed, the observations stemming from this study strongly suggest that the disease known as cystic fibrosis can be due to homozygosity of genes at two distinct loci. However, no correlation between the two morphological classes of fibroblasts seen in culture and the clinical form of the disease is clearly evident. It should be stressed that the presently convenient classification of the morphological findings into class I and class II will be modified and extended as additional cases are studied and our understanding of the cellular aspects of the disease increases.
The finding of a recognizable cytological abnormality in skin fibroblasts in cultures derived from affected individuals and heterozygous carriers and fibroblast cultures derived from 11 different organs from two affected individuals strongly suggest that the basic defect in cystic fibrosis affects not only the exocrine cells but is a mulficeUular disorder involving connective tissue. The existence of a recognizable abnormality in fibroblasts grown from affected and heterozygous carriers, under known controlled conditions in culture, not only will make possible the detection of heterozygotes but will also provide an in vitro model for studying the primary cellular defect.
S~/kRY
103 individuals from 16 families with cystic fibrosis and 87 individuals without family history of cystic fibrosis have been studied using the methods of cell culture. Skin fibroblast cultures derived from 19 affected children, and fibroblast cultures from 11 different organs obtained at autopsy from two affected children, showed cellular metachromasia. The morphological appearance and the intracellular mucopolysaccharide content enabled these cultures to be divided into two distinct classes. Class I had discrete cytoplasmic metachromatic vesicles and a mucopolysaccharide content similar to that observed in normal fibroblasts. In class II the metachromasia was present in both vesicles and granules and was evenly distributed throughout the cytoplasm. The mucopolysaccharide content of these cells was markedly increased.
The cultures derived from the parents, presumed heterozygotes, and other members of each family showed cells with the same type of metachromasia as that demonstrated by the propositus. These data strongly suggest that cystic fibrosis is not a homogeneous entity and, moreover, can be caused by homozygosity of genes at two distinct loci.
The recognition of cytoplasmic abnormalities in skin fibroblasts derived from affected individuals and heterozygous carriers for cystic fibrosis should facilitate genetic and biochemical studies on the heterogeneity of this inborn error of metabolism. 
